Form 8-K - Current report:
SEC Accession No. 0001193125-10-290075
Filing Date
2010-12-29
Accepted
2010-12-29 14:13:02
Documents
3
Period of Report
2010-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17675
2 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND MARC RUBIN dex101.htm EX-10.1 5337
3 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND SUNIL BHONSLE dex102.htm EX-10.2 5020
  Complete submission text file 0001193125-10-290075.txt   29774
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 101277945
SIC: 2836 Biological Products, (No Diagnostic Substances)